about
Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.First complete genome sequence of infectious laryngotracheitis virus.Attenuated vaccines can recombine to form virulent field viruses.Phylogenetic and molecular epidemiological studies reveal evidence of multiple past recombination events between infectious laryngotracheitis viruses.Growth kinetics and transmission potential of existing and emerging field strains of infectious laryngotracheitis virusPrevalence and Clinical Significance of Herpesvirus Infection in Populations of Australian MarsupialsProtection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.The first genome sequence of a metatherian herpesvirus: Macropodid herpesvirus 1.Identification of unusual Chlamydia pecorum genotypes in Victorian koalas (Phascolarctos cinereus) and clinical variables associated with infection.Low genetic diversity among historical and contemporary clinical isolates of felid herpesvirus 1.Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.Bayesian Validation of the Indirect Immunofluorescence Assay and Its Superiority to the Enzyme-Linked Immunosorbent Assay and the Complement Fixation Test for Detecting Antibodies against Coxiella burnetii in Goat SerumChlamydia pecorum Infection in Free-ranging Koalas ( Phascolarctos cinereus ) on French Island, Victoria, Australia.The prevalence and clinical significance of Chlamydia infection in island and mainland populations of Victorian koalas (Phascolarctos cinereus).Immune responses to infectious laryngotracheitis virus.Challenges and recent advancements in infectious laryngotracheitis virus vaccines.Differential transcription patterns in wild-type and glycoprotein G-deleted infectious laryngotracheitis viruses.Impairment of infectious laryngotracheitis virus replication by deletion of the UL[-1] gene.Development and Validation of TaqMan Real-Time Polymerase Chain Reaction Assays for the Quantitative and Differential Detection of Wild-Type Infectious Laryngotracheitis Viruses from a Glycoprotein G-Deficient Candidate Vaccine Strain.Impacts of poultry vaccination on viruses of wild bird.Koala retrovirus genotyping analyses reveal a low prevalence of KoRV-A in Victorian koalas and an association with clinical disease.Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1Marsupial and monotreme serum immunoglobulin binding by proteins A, G and L and anti-kangaroo antibody.Natural recombination in alphaherpesviruses: Insights into viral evolution through full genome sequencing and sequence analysis.Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.Peripartum dynamics of Coxiella burnetii infections in intensively managed dairy goats associated with a Q fever outbreak in Australia.A high prevalence of beak and feather disease virus in non-psittacine Australian birds.Infectious Disease Surveillance in the Woylie (Bettongia penicillata).Immune responses to vaccination and infection with Mycoplasma gallisepticum in turkeys.Spread of the newly emerging infectious laryngotracheitis viruses in Australia.A longitudinal study of serological responses to Coxiella burnetii and shedding at kidding among intensively-managed goats supports early use of vaccines.Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.Evaluation of a novel strain of infectious bronchitis virus emerged as a result of spike gene recombination between two highly diverged parent strains.Assessment of the potential relationship between egg quality and infectious bronchitis virus infection in Australian layer flocks.Comparing the genetic diversity of ORF30 of Australian isolates of 3 equid alphaherpesviruses.Detection and identification of a gammaherpesvirus in Antechinus spp. in Australia.Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.A glycoprotein I- and glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells.Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
P50
Q33560566-86DCC5FC-12DF-410F-B445-6B303966BC7AQ33876002-0E673182-3975-4055-B7AC-C4C7575E7231Q34288335-A4A0E46F-A8E9-488B-942D-F0F6B43944E1Q34577058-8BFA38B5-0A0E-494E-8C05-85744AB5922BQ35192770-1559561E-B54E-4A53-942F-D082E154BCD3Q35723673-A76498DC-AEFC-43CB-80A6-220F6983BDFFQ35772273-E1C9D6DB-C0CB-4A5B-8FE7-186B5F336278Q35901924-7877E8E2-4CD9-46B8-8621-382FFCAE1B40Q35942445-A399EC6D-204B-4F41-874A-9E5A78D322BFQ36121891-E73639DC-0645-446C-9D93-908BAF353C75Q36325388-7D190342-4F8D-49F1-B6A0-88AAC981853FQ36973958-CB788228-E22C-46A0-8CE7-2C3A0151E209Q37837076-E0F75C00-EE42-400D-9AE2-D4EC56113848Q37842266-C03E3E8F-9A63-40D7-92C4-7CA988D71594Q38097266-CFD56B13-D9C0-4EEA-9F6A-29D6FD5D2B7DQ38110339-0D58B020-3D12-4C22-B17D-911013AC0B68Q38316082-43D6673A-A3E6-4300-9134-1D77FF023709Q38716586-14F7046F-7F38-476D-959B-8B2A5D9266ADQ38842246-3BEB6AFC-DFB4-4A2C-B217-8FBDF49DF15CQ38881619-F81CEED7-12B3-4C9F-B294-A172F87DDF49Q38925558-2EC8E554-11D0-4265-8991-7AAA896EE1BEQ38929399-92A8469A-34DC-4A1C-83B8-D32AA8F31738Q38947497-0C1E1FFA-03E0-4588-AD34-2AD8999A0CEAQ39054773-C8D404A0-93A0-4606-A70D-E556D1473665Q39737403-329E979A-6E9C-46E3-B864-8CBE6A3052C3Q40062987-4164DC48-4F72-4E04-AD63-2026301D1111Q40124480-26E47567-5ACB-4518-8770-D4FE057D41CAQ40151764-99E00121-0786-4A50-B8AE-65FC2955FD55Q40277467-E459C7E6-3F87-45BE-B650-4BD7B588A190Q40660330-6980F622-691C-456D-9150-FFA85C3F2076Q41718773-56FC4B4A-BFF8-410D-9F8E-B2B215EE2631Q41931848-C8683DE3-E6E0-469A-8FAD-CD617FB07480Q42218186-7D7ADADF-7B18-443D-A7CE-49AEFDA8DC0EQ42219491-950448F6-147A-40F3-9F93-EBFADF1B93E8Q42222005-F3C8ACB8-DE20-4A07-B773-D859015F593EQ42233218-F4C56376-F6CA-4D69-B749-C9DD24082232Q42238929-D88D4ECC-5442-40CE-9850-B9F1B665D035Q42623243-D5CE84B9-F000-4D18-885A-484E3EBC8195Q43637325-9AEF795B-A8C9-45FD-B369-EB33CB3B4CAAQ43931339-F8800008-2269-4042-8082-E44EC9BFDAF6
P50
description
Australian veterinary scientist researcher
@en
onderzoekster uit Australië
@nl
հետազոտող
@hy
name
Joanne M Devlin
@nl
Joanne M Devlin
@sl
Joanne M. Devlin
@en
Joanne M. Devlin
@es
type
label
Joanne M Devlin
@nl
Joanne M Devlin
@sl
Joanne M. Devlin
@en
Joanne M. Devlin
@es
altLabel
Joanne Devlin
@en
Joanne Maree Devlin
@en
prefLabel
Joanne M Devlin
@nl
Joanne M Devlin
@sl
Joanne M. Devlin
@en
Joanne M. Devlin
@es
P1153
14025458900
P21
P27
P31
P496
0000-0003-0400-9670